Taysha Gene Therapies, Inc. · NASDAQ:TSHA

Octagon Capital Advisors LP's stake in Taysha Gene Therapies, Inc. fell to 3.30% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Octagon Capital Advisors LP's stake in Taysha Gene Therapies, Inc. fell to 3.30%, 9,067,500 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.30%
Shares
9,067,500
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP3.30%9,067,500
Octagon Investments Master Fund3.30%9,067,500
Ting Jia3.30%9,067,500

Source

View original at SEC

Related